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Lymphatic lymphocytes undergo a 
limited or controlled degree of multiplica-
tion for ordinary immunity, which is a 
defence mechanism. Lymphatic lympho-
cytes undergo unlimited or uncontrolled 
multiplication in lymphatic leukaemia. 
Therefore lymphatic leukaemia is, or can 
be likened to, an uncontrolled defence 
mechanism. But leukaemia is a cancer. So 
at least one form of cancer is, or can be 
likened to, an uncontrolled defence mech-
anism. 
This being so, it would be reasonable 
to conceive of some other forms of cancer, 
if not all, as being uncontrolled or unlimit-
ed defence mechanisms - in other words, 
a form of immune response. (There is evi-
dence for the existence of host-to-tumour 
response in the case of implanted tumours, 
but that is beyond the scope of this paper). 
The pure logic of the above seems unas-
sailable. Whether the conclusion is indeed 
correct or not depends on further evidence. 
This further evidence is at hand. 
What other features are there in com-
mon between cancer and immunity against 
ordinary bacterial infection? Conversely 
what are the contrasts between cancer and 
ordinary immunity and can the contrasts 
or paradoxes be explained away as excep-
tions that prove the general rule of simi-
larity? What would be the factor in can-
cer corresponding to the bacterial antigen? 
It is here suggested that this is the carci-
nogen itself. With regard to similarities, 
the majority are already widely known; 
others will be explained and supported by 
"All that can be asked of a theory 
is that it shall be concordant with 
developing understanding in related 
fields of knowledge and that it shall 
imply certain experimental conse-
quences which can be tested." 
F. M. Burnet, Science Journal, 
September 1965. 
reference to original articles. Antibacterial 
immunity being salutary, and cancer being 
definitely the opposite, a slight mental 
effort will be necessary to accept them as 
being essentially parallel processes. 
1. Immunity is preceded by an incu-
bation period. Cancer is preceded - cer-
tainly in some known forms - by a pre-
cancerous period. In other forms, the lat-
ter is not excluded. 
2. Reaction to a single isolated dose 
of a vaccine may never become established 
immunity. Cancer-in-Situ, unless carcino-
genic action is continued, might never be-
come established cancer. 
3. Immunity is strengthened with 
each new dose of vaccine. Cancer gets 
more active with each new application of 
carcinogen (cfr. shoe-shop girls and view-
ing boxes and the necessity of repeated 
applications in experimental carcino-
genesis). 
4. Well-established immunity is diffi-
cult to overcome by further infection. A 
tumour that recurs answers poorly to ra-
diation. 
5. Immunity is heritable (this is 
known). There is a linear transmi~sion of 
immunity to bacterial infection. Asthma 
is also transmissible, and what is asthma 
if not another form of immune reaction? 
Therefore an analogy triad is formed by 
Immunity - Allergy - Cancer. 
The tendency to cancer can be inher-
ited, as is known in the case of mammary 
cancer-prone rodents. Sarcoma in mice is 
heritable (Richmond, 1959a). Murine leu-
kaemia is transmitted vertically, a low 
strain becoming a high leukaemia strain 
(Heston, 1965 and Salaman et al., 1963). 
6. In old age, general immunity is 
retarded (Court-Brown, 1963). Cancer is 
resisted by the very old. 
7. All sorts of organisms, including 
viruses, can produce an immune response. 
All sorts of carcinogens, including viru-
ses, can produce cancer. Here we have a 
link as well as a parallel. There is also, in 
a sense, a contrast. Bacteria and infectious 
viruses produce a type of disease which 
depends on the type of infecting organism. 
Chemical carcinogens and oncogenic viru-
ses produce types of tumour which depend 
on the type of cell affected. This leads one 
to consider the possibility that in certain 
conditions when circulating specific anti-
bodies cannot neutralize an antigen (here 
carcinogen) non-specific local tissue cells 
proliferate in an attempt to take on that 
function, the resulting tumour being a 
cancer. Tumour-producing viruses are by 
no means all related (Andrews, 1964) yet 
there is no essential difference between 
viruses that cause tumours and those that 
cause disease. This gives us not only an 
analogy but an actual overlap of anti-
genicity and carcinogenicity. 
8. There is a cellular mode of immu-
nity independent of circulating antibodies 
(Waiter and Israel, 1965a). Children with 
agammaglobulinaemia still recover from 
measles, etc. Cancer can be induced by 
adding viruses to a tissue-culture medium 
(Berwaldy and Sachs, 1963) 
9. Lymphocytes and antibodies are 
obviously parts of "Self". There appears 
to be enough evidence pointing to the fact 
that a primary, that is, carcinogen-induced 
tumour, is also part of "self", for instance: 
(a) No antibodies coat the cells of a spon-
taneous tumour (Harveitt, 1966); (b) Im-
mune reaction to own growth is negligi-
ble (Everson, 1964); (c) Antibody to own 
spontaneous tumour is never found (Czaj-
kowski et al., 1967); (d) A protein antigen 
is absent in basal-cell carcinoma (Roth-
berg et al., 1964). 
10. Is a hormonal element involved 
in immunity? As is well known a hormonal 
element is certainly involved in cancer. 
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11. Irradiating the whole body de-
immunizes. Irradiating the whole body pro-
duces remissions in Hodgkin's disease. 
12. (Concluding the Analogy). Im-
munity is a protracted defensive response 
to bacterial infection. In view of the nu-
merous similarities listed above, it would 
seem reasonable to regard cancer as an 
exaggerated and protracted defence mech-
anism or immune response against carci-
nogens. Unfortunately for the host, that 
is where the similarity stops. The highly 
beneficial character of antibacterial immu-
nity is contrasted sadly and tragically 
with that of cancer, very understandably 
described as malignant or evil. Now why 
should two essentially similar processes, 
if this is what they are, both apparently 
starting off as a protective mechanism, de-
velop so differently? An answer might lie 
in their contrasting features. 
Contrasting features 
1. In the early neonatal period, the 
body is, except for inherited antibodies, 
immunologically defenceless, the immune 
mechanism not being as yet in full func-
tion. Yet, also in the early neonatal period, 
polyoma virus and chemical carcinogens 
are more successful (Brit. med. J. 1963 and 
Waiter and Israel, 1965). If as suggested by 
similarities, a cancer is a form of immune 
response ,how would it be explained that it 
is more active precisely at a period when 
circulating immunity is at its lowest ebb? 
One explanation would be that tissue im-
munity comes into play when and because 
circulating immunocytes and their anti-
bodies cannot deal satisfactorily with those 
substances that have come to be called 
carcinogens. This may happen not only 
when circulating immunity, as in neonates, 
is not yet properly established, but also 
when the carcinogen is partly or wholely 
out of reach of the circulating immuno-
cytes, or else because, having established 
contact, the latter are unable, for mecha-
nical reasons, to dispose of them as they 
would of bacteria or of other foreign ma-
terial The tissue cells nearest the invad-
ing particles attempt to do the work left 
undone by circulating cells, but, not being 
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anatomically constructed or suitably sited 
for the purpose, even if they did succeed 
in ingesting a minute proportion of carci-
nogen, they would find it physically im-
possible to remove it into the circulation. 
The line of cells directly in contact with 
the particles not only cannot remove the 
latter but themselves block the way for 
circulating cells to act. 
Trentin and others since 1962 have 
shown that adenovirus of types 12 and 18 
when inoculated into newborn hamsters or 
rats cause sarcoma in a high proportion 
of the animals (Documenta Geigy, 1964). 
Therefore these viruses, normally infec-
tious, are carcinogenic when circulating 
immunity is in abeyance. Also, Gross 
(1961) produced lymphoid leukaemia only 
if the mice were inoculated within 12 days 
of birth (Gross, 1961). The reason would 
appear to be the same. The lymphoreticular 
system is more active in strains with low 
incidence of spontaneous tumours (Stern, 
1960). This could be interpreted as mean-
ing that, because of an active lymphoreti-
cular system, local tissue cells are not 
called into action. 
Even for lymphocytes to be of any use 
in immunity, they must be mobile (Burnet, 
1962). A classical example is the condition 
in obstructive lymphoedema where the 
part is packed with extravasated lympho-
cytes and yet infection is very easily es-
tablished. The reason being of course, that 
the cells are prevented from leaving the 
affected zone. 
2. In late middle age circulating im-
munity diminishes. In late middle age can-
cer increases. Here again the apparent 
paradox is explained, if we accept that 
tissue immunity (i.e. the tumour) takes 
over when circulating immunity fails. 
3. The lymphoreticular system is 
more active in established bacteria! immu-
nity. This is known for a fact. Lymphoid 
tissue as a whole is more active in tumour-
resistant animals (Murphy, 1926); in other 
words, tissue immunity is strong. 
4. The cells involved in bacterial 
immunity are "regular" circulating immu-
nocytes. The cells involved in cancer are 
the "territorials", i.e. any tissue cells. With 
these we include bone marrow and the 
lymphatic tissues whose cells naturally 
overflow into the circulation. To carry the 
immunity-cancer analogy to a practical 
conclusion: Bacterial immunity may be 
suppressed or "paralysed" (Medawar, 
1968a). Would cancer be inhibited by 
giving high doses of carcinogen? This as-
pect will be dealt with more fully later on. 
When local tissue cells proliferate in 
a vain attempt to reject, encapsulate or 
phagocytose the carcinogen particles, re-
peated applications of the latter stimulate 
proliferation even further. Supposing 
healthy tissue cells normally produced 
mutants every so often, these would be-
come suppressed. But if normal tissue cells 
were devitalized by carcinogen, this might 
create better conditions for the mutants 
to survive in and become relatively "suc-
cessful" in the evolutionary sense. With-
out any need of departing from the ori-
ginal idea of an immune response, these 
mutants (or cancer cells) would be the 
immunocytes evolved to neutralize the 
carcinogen particles - if only they could 
reach them. As it is the larger the tumour 
grows, the further away from the carci-
nogen do the newest cells accumulate, 
their "success" having been absolute. It is 
a sort of static warfare with progressive 
building up on either side and very few 
casualties. 
If, at a very initial stage, the mutated 
(i.e. cancer) cells could have overcome the 
carcinogen entirely, the small balance of 
uncommitted cancer cells could have been 
themselves suppressed - and another 
"cancer-in-situ" or "pre-cancer" would 
have resolved. As the body is being con-
tinually bombarded by carcinogens of all 
sorts, it is here suggested that "cancer-in-
situ" is not only common but a regular 
physiological occurrence, which only ex-
ceptionally fails to produce an early reso-
lution and proceeds to establish a cancer. 
We shall never know even the approxim-
ate number of precancerous conditions any 
more than we shall ever know the num-
ber of undetected crimes. 
Carcinogenesis 
It is now generally agreed that pure 
irritation or trauma, however often re-
peated, is not sufficient to cause malignan-
cy. On the other hand, it is also generally 
agree that chronic irritation or trauma is 
a definite adjuvant towards malignancy in 
the presence of carcinogens. 
Some carcinogens are notoriously 
strong and only a small number of appli-
cations of them are sufficient to produce 
malignancy; others are weakly carcino-
genic and a large number of applications 
are required in their case. Still other sub-
stances, not normally regarded as carci-
nogenic at all, given certain conditions, 
produce cancer. In the paragraphs that 
follow an attempt will be made to show 
why this is so. 
Tattooing, even if covering a large 
surface, or even the whole body, does not 
produce cancer, and the histological find-
ings are only one layer of macrophages 
(WaIter and Israel, 1965b). This is a form 
of foreign body reaction. Would it rest at 
that if tattooing were repeated over and 
over again at one and the same site? Tat-
tooing is in one layer and one layer of 
macrophages can cope. 
Certain chemicals, such as hydrocar-
bons, are notorious for their carcinoge-
nicity, yet even these have to be applied 
at the same site repeatedly before mali-
gnancy is produced. Iron injections repeat-
ed at different sites in therapeutic doses 
never produce sarcoma (Haddow et aI., 
1964). Even an Iron-induced tumour starts 
off with histiocytes containing iron (Rich-
mond, 1959b). 
This stage is analogous to a tattoo-
reaction. Iron particles injected therapeu-
tically (and therefore discrete) appear in 
phagocytes and in connective-tissue cells 
(Goldberg, 1960). Iron injected in large 
quantities at the same site produces 
sarcoma. 
Obviously, then, Iron, though not car-
cinogenic in the ordinary way, at a certain 
concentration and repeated often enough 
can devitalize normal tissue cells suffi-
cietly to encourage the survival of their 
mutants. 
The fate of various types of inhaled 
particles in the !ungs and the reaction they 
provoke also have something to tell us in 
relation to carcinogenesis. 
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Coalminer's Pneumoconiosis. Here, 
inhaled carbon particles are transplanted 
by macrophages to the lymphoid tissues 
in the lung, where they remain throughout 
life. "Coalminer's pneumoconiosis... pro-
bably produces little disability by itself; 
it is the associated chronic bronchitis 
which is crippling" (WaIter and Israel, 
1965c). So, it appears, cancer of the lung 
is not produced as a result of carbon in-
halation although this is repeated regu-
larly sometimes for most of a lifetime. A 
man can have lungs black with coal-dust 
yet die in old age from something quite 
different. The reason would be that macro-
phages, which are circulating cells, are 
quick enough in their action to cope with 
the particles as they settle in a fine layer 
on the epithelial surface, and carry them 
away before they get out of hand. The 
epithelial cells themselves are not then 
called into action, and there is no need for 
them to multiply unduly. What is more, 
any tobacco smoke in these cases would 
be dealt with by the already mobilized 
macrophages. As a matter of fact lung-
cancer in tobacco smoking coal miners is 
rare. This is an extreme example of gene-
ral and local immune responses being in 
inverse ratio. 
Lung Silicosis produces an almost 
identical response. Not so Asbestosis. The 
asbestos fibres are large relatively to coal 
and silicon particles, and they form seve-
ral local foreign body reactions, as they 
cannot be carried away by circulating cells. 
This involves rapid proliferation of sur-
rounding cells, which is accelerated by the 
continuous supply of freshly inhaled par-
ticles. Local mutated cells, which would 
normally be suppressed become "success-
ful" in their new way of life and prolifer-
ate unhindered in the shape of a malignant 
growth. The analogy here is between a 
foreign-bodv reaction and cancer, complet-
ing the ch;:tin as a Foreign body-Allergy-
Immunity-Cancer analogy. 
One can well understand mutation 
taking place as the result of direct inter-
ference bv a virus with cell-chromo-
somes. It is not so easy to visualize how 
a relatively large extracellular obiect such 
as an asbestos thread can indUCe the same 
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change. But. without the necessity for de-
parting from the Immune Response Theo-
ry, the "Cellular Evolution Theory" sug-
gested above would account for it. 
Sawdust has recently been found to 
be the cause of nasal and sinus cancer- in 
wood workers (Acheson et al., 1968). The 
oncogenic mechanism might be the same 
as for asbestos. 
Certain Viruses produce cancer (e.g. 
the Rous sarcoma). Here the individual 
viruses could very well act inorganically 
like any other particulate carcinogen, the 
"repeated application" being provided by 
their biological multiplication. It is known 
(Therap. Notes, 1960) that these viruses 
interfere very intimately with the genes 
probably causing mutation in this way, 
and therefore superadded on the mutation 
normally taking place. 
Endogenous Carcinogens could be the 
cause of spontaneous tumours according 
to data by P. A. J. Bentvelzen and G. A. 
Zalay of Amsterdam (1965). According to 
the Local Immunity theory - or the cell 
Evolution theory - either is applicable -
the mutated or cancer cells have now be-
come immunocytes potentially better 
equipped than normal cells to deal with 
the invader, even though the younger 
generations are so far removed from the 
viruses themselves that they might never 
even make contact with them. This would 
be evolution at cell level analogous to that 
which Burnet (1965a) applied to immunity. 
It is known that a higher type of animal 
organism might evolve to fight or fly from 
a natural oppressor even though their res-
pective future generations may never 
meet, for instance cetaceans and the de-
scendants of their former land-dwelling 
enemies. Why should this not also take 
place at cell-level? 
If cells susceptible to carcinogenic 
viruses are acted upon instead by a che-
mical carcinogen, or even by radiation. an 
identical type of cancer is produced. This 
means that any given tissue cell can mutate 
in one way and one way only. and the 
character of the causative agent, whether 
chemical, viral, or radiation, becomes 
somewhat insignificant once proliferation 
of the mutated cell is a fait accompli. The 
reader is therefore being asked to accept 
not one contention but two, each of which, 
however, lends support to the other: 
(i) The anthropocentric view that 
normal tissue cells have changed into im-
munocytes and as such increase and mul-
tiply to a degree far beyond that required 
for ordinary and immediate body defence 
purposes. (This covers the pre-cancerous 
reversible stage) and 
(ii) The more detached, biological 
view that ordinary tissue cells, forming 
part of an organized whole, when reacting 
to -the presence of certain noxious par-
des, whether chemical, viral or radiation, 
partly survive in a mutated form, in accord-
ance with recognized laws of evolution, 
but completely relieved of all responsibility 
to the parent body, and in this form in-
crease and multiply, the resulting tumour 
being not only a useless parasite but also 
a deadly one. It is now selfishly concerned 
only with its own survival and propaga-
tion. 
Any good that might have been done 
by the mutated cells' first role (immunity), 
is therefore limited only to the precancer-
ous period, and far outweighed by the 
harm done in its second role, that of strug-
gling for its own primitive existence. 
As an extreme reductio ad absurdum 
we may even go as far as to say that 
broadly and biologically speaking: mali-
gnancy does not exist. It is generally 
agreed that an epithelioma establishes it-
self as malignant when the basement mem-
brane is pierced. There is no basement 
membrane where sarcoma is concerned, 
and this may account for its early mali-
gnancy. 
When bacteriophage - a virus - at-
tacks bacteria, either they are destroyed 
or new types of bacteria emerge. This is 
another example of immunity through 
evolution at cell level. Owing to the natu-
ral barrier at the tissue-carcinogen fron-
tier, malignant cells grow mainly inwards, 
away from the carcinogen. This would 
explain the following apparently paradox-
ical observation: 
(i) That "chemical carcinogen disap-
pears as the tumour grows" (Rous, 1947). 
Naturally, the larger the tumour grows, 
the less likelihood is there for carcinogen 
to be included in the biopsy material. Again 
"Chemical carcinogens attach themselves 
to neighbouring tissues but not to the cells 
of the cancer they have induced" (Walter 
and Israel, 1965d). The reason, of course, 
would be the same. 
(ii) "Fe-induced tumours later lose 
their avidity for iron" (Richmond, 1959c). 
The avidity is still there, but contact is 
impossible. 
(iii) "Viruses cause cancers yet are 
not demonstrable in cells" (Andrews, 
1964). By the time a tumour is diagnosed 
it has grown out of all proportion to the 
causative viruses. 
Radioactive substances produce can-
cer. Here again, it is not the type of radio-
active substance that determines the type 
of growth, but the type of cell affected -
as for chemical or viral carcinogenosis, 
the surviving mutated cells being identical 
with those from these latter causes. This 
should simplify treatment which could 
therefore, at least theoretically, be the 
same for all. 
Something which may just be men-
tioned in passing at this stage is what 
Julian Huxley calls "multiple correlation". 
It is beyond the scope of this paper to go 
into its details. It can be said however 
that certain factors enhance the effect of 
the principal carcinogen; these are: tem-
perature, primitivity of cells affected, pH, 
anaerobic metabolism etc. This aspect of 
the matter might lead to other lines of 
approach to the problem of cancer and its 
treatment, and could be made the subject 
of a further paper. 
Carcinogens, therefore, are varied in 
nature being either chemical, viral, or the 
effects of radiation. To this list it is sug-
gested physical be added as well. This 
would take in particulate foreign bodies 
like asbestos, sawdust, jute, etc. (Daily 
Telegraph, 5th July, 68, p. 21, col. 1) which 
are receiving more notice of late. What is 
it, then, that all these widely different 
agents possess in common which enable 
each of them, if applied often enough at 
the same site, to provoke cancer? At first 
sight, very little if anything at all. Yet if 
the negative aspect is considered, it will 
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be ~;een where they agree: in that none of 
them can (I repeat, if reapplied often 
enough at the same site) be disposed of 
by the usual protective mechanisms of the 
body, which are: 
(i) Rejection, an allergic reaction as 
for pollens, some other foreign proteins, 
homografts, etc. 
(ii) Immune Response, as for dispo-
sal of foreign virus microorganisms and 
macromolecules by the reticuloendothelial 
system, and 
(iii) Encapsulation, as for foreign 
bodies. 
The survival and rapid multiplication 
of mutated cells is an attempt to substi-
tute any of (i), (ii) or (iii), which unfor-
tunately, is thwarted by local phyisical 
conditions. 
The Theory 
It is felt that enough has been said 
above to justify an enunciation. Cancer is 
a progressive and irreversible local im-
mune response by static tissue cells 
against certain particulate substances 
which cannot be disposed of by the cir-
culating immune mechanism. The response 
consists in a survival of mutated tissue 
cells, the mutation being caused in some 
cases by direct interference with the cell 
genes by carcinogens. The mutated cells 
(alias the cancer cells) have the potential 
nature of immunocytes, though this fun-
ction is permanently frustrated owing to 
insufficient contact between cancer cells 
and carcinogen. The cancer cells increase 
and multiply for two reasons: firstly be-
cause, as immunocytes ,they cannot rest 
till all antigen (here the carcinogen) is 
disposed of ,and secondly because they 
have evolved into a successful colony of 
unicellular organisms which lives as a 
parasite on the body as its pabulum com-
pletely regardless of the host's economy. 
As a "give away" corollary to this 
theory, by reversing the analogy, immune. 
cells could possibly be regarded as mutat-
ed RE cells (as for tissue cells) each micro-
organism producing its own type of anti-
body (Burnet, 1965b). It is known that any 
macromolecule can produce an immune 
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response (Coombe, 1968). Is this not un-
cannily reminiscent of carcinogenosis? 
Note that leukaemias are included 
here as local tissue tumours. In any ma-
lignant disease, however localized this may 
be, cells are always found in the blood. 
Owing to their origin in the haemopoietic 
system, leukaemic cells find themselves in 
the circulation more readily and more 
abundantly, but for the purpose of the pre-
sent argument, this system is considered 
static. So any distinction would really be 
one of degree not of essential nature. 
Treatment 
Surgery for established cancer, though 
sometimes successful, is at best mutilating. 
Regarding Cytotoxics, it is true that 
cancer cells are destroyed by them, but so 
are leukocytes, and no cytotoxic drug is 
really effective as such without also caus-
ing leukopoenia (Brit. med. J., 1965). 
In Irradiation we have a long-tried 
ally. Deep X-rays penetrate into the depths 
of the tumour which is out of reach of the 
causative carcinogen. Radioactive gold 
cures established melanoma when injected 
into limb lymphatics (Jantet et al., 1964) 
but X-rays travel in straight lines and, as 
is known only too well, might miss some 
peripheral cells. Also, ionizing radiation 
can inhibit growth of normal as well as 
neoplastic tissue (Starikova et aI., 1962). 
However, we are very grateful for radia-
tion, in spite of its drawbacks. But is it 
the final answer? As far as the present line 
of argument is concerned X-rays do show 
beyond doubt that at least one type of 
carcinogen can be used to treat cancer. 
Trypan-Blue, known to be cytotoxic, 
is also mentioned as an immuno-suppres-
sive agent (Medawar, 1968). 
"Hektoen used Mustard Gas (Dichlo-
rethylsulphide) as an immuno-suppressive 
agent as far back as 1917, and the history 
of the use of X-rays for that purpose is 
, even older" (Medawar P., 1968b). Here we 
have two agents both for immuno-suppres-
sion and as cytotoxics in cancer. So why 
not use the other immuno-suppressive, 
namely Immunological Paralysis, as a can-
cer inhibitor? We know what carcinogen 
particles do to normal cells - they turn 
their descendants into cancer cells. What 
would carcinogen particles do to cells al-
ready cancerous with which they came into 
contact? The following list seems to cover 
all possibilities: 
(i) Nothing at all. 
(ii) Cause a second abnormal mu-
tation. 
(iii) Revert them to the original con-
dition of the normal parent cell. 
(iv) Destroy them directly, or indir-
ectly by cytostasis. 
Let us consider these possibilities in 
turn. 
(i) No action at all. This could well 
be, in which case this whole theory of an 
immune response falls through and there 
is nothing more to say for it. Therefore 
what follows is based on the theory being 
valid. 
(ii) Cause a second mutation. This, 
though theoretically possible, is not borne 
out by present knowledge of cancer cells. 
Cells of a given cancerous growth, once 
established, have never been known to 
undergo a second mutation. 
(iii) Revert them, i.e. mutate them 
back to normal parent tissue cells. This, 
of course, would be a very good thing, but 
is not very likely, as evolution is progres-
sive. 
(iv) Destroy them directly, or indir-
ectly, the latter by cytostasis. This seems 
the only alternative left when the other 
three are eliminated. But it also has merits 
of its own. Having accepted the theory of 
immunity, we must also accept that the 
cancer cell, as an immunocyte, combines 
with the carcinogen particle in some way, 
perhaps even phagocytosing it. Carcino-
gens interfere with cell metabolism, some-
times, as in the case of viruses, by acting 
directly on the genes. It is therefore not 
unlikely that something similar would 
happen with cancer cells, whose biological 
mechanism would thus be seriously inter-
fered with. This interference, as we have 
seen, does not produce a second 'forward" 
mutation, is not likely to cause a "reverse" 
mutation, and we are therefore left with 
direct destruction of the cell, or, the next 
best thing, cytostasis. 
"Pre-cancer" and "cancer-in-situ" 
cells are cancer cells like any others, and 
yet, as in the case of the lung, they have 
been known to disappear when the sub-
ject, e.g. stopped smoking. The cessation 
of supply of carcinogen in this case might 
have allowed such an action as the above 
to take place and effected a complete cure. 
The above, of course, can only hap-
pen if cancer cells can reach their targets, 
the carcinogen particles. Unfortunately 
the cells tend to multiply and spread deep-
ly further and further away from the carci-
nogen and contact becomes well nigh im-
possible. 
Now supposing fresh carcinogen -
almost anyone would do, not necessarily 
the causative one (it will be remembered 
that, once cancer is established, the nature 
of the cause becomes irrelevant) - could 
be introduced into the body in such a way 
that it reached each and everyone of the 
tumour cells, the above result might be 
achieved. Owing to the compactness of 
the tumour we are here faced with the 
difficulty or perhaps impossibility of the 
particles pervading the intercellular spaces 
of the tumour as we would wish. This is 
where the spreading factor hyaluronidase 
could come to _ the rescue. If carcinogen 
particles could be administered system-
ically in solution in or with hyaluronidase, 
there is a possibility that they might reach 
the tumour before they could have any 
effect on normal body cells en route, and, 
once they reach the tumour, they would 
infiltrate (by virtue of the accompanying 
hyaluronidase) all its interstices to where 
they could be acted upon by, and act on 
the tumour cells. 
The chances of the carcinogen parti-
cles harming normal cells en route would 
be minimal (though this, of course would 
have to be checked by animal experiment) 
because particles are discrete when given 
in this way; at the worst, the excess might 
be taken up by phagocytes and wasted. 
If they did get as far as the tumour it is 
hoped that they would be pounced on by 
the cancer "immunocytes", if there is any 
truth in the theory that after all these 
evolved with a view that one day they 
should neutralize their natural enemy the 
carcinogen. 
109 
The principle of bombarding cancer 
cells with carcinogen therapeutically would 
in effect only be an application of the Im-
munity Theory; for it is well known that 
one method of de-immunization is pre-
cisely to bombard antibodies with antigen. 
In support of the above purely theo-
retical reasoning, there is some useful 
experimental evidence, which shows that: 
(a) A well-known carcinogen has 
inhibited cancer growth; and 
(b) Hyaluronidase could be a suit-
able vehicle. 
(a) Starikova and Vasiliev (1962) 
experimented with rat sarcoma in vitro. 
They found that high concentrations of 
Dimethylbenzanthracene (DMBA) com-
pletely prevented the outgrowth of nor-
mal fibroplasts but they also found that 
the same carcinogenic hydrocarbon inhi-
bits growth of normal and of neoplastic 
tissues. Small and moderate concentra-
tions of DMBA were resisted by sarco-
mata whether HC-induced or cellophane-
induced. (As suggested above, the causa-
tive carcinogen loses its importance once 
malignancy is established.) However, -
and this is of great importance - DMBA, 
in highest concentrations only, caused 
partial or complete inhibition of sarcoma 
cultures. 
The principle has therefore been es-
tablished that a chemical carcinogen can 
inhibit the growth of a chemical-carcino-
gen-induced malignant tumour. This is, of 
course, a tremendous step forward. But, 
having established this principle, the next 
question is: why did the DMBA not inhibit 
the tumour completely and every time? 
The answer suggested here is that even 
the strongest concentration was not always 
able to find its way through the tumour's 
intercellular spaces to seek out each and 
every cell, the obstacle, of course, being 
the intercellular ground substances. This 
brings us back to the ground-substance 
liquifier Hyaluronidase which is found so 
useful clinically for the spreading of in-
jected substances and for preventing the 
formation of haematomata. Dyes into the 
skin diffuse better with hyaluronidase 
WaIter and Israel, 1965e) it can even be 
used subcutaneously with opaque sub-
stances for LV.P.'s. Hyaluronidase is safe 
llO 
to administer systemically (Popper, 
1967) and anyway its action on tissue is 
reversible. As is well known, an allergen 
alone applied to the skin of a sensitized 
person causes a severe allergic reaction. 
If the allergen is applied to the sensitized 
skin together with hyaluronidase, not only 
is there no side-effect, but it desensitizes 
the existing allergy (Potter, 1967). This 
shows: 
(i) 
(ii) 
that spread of hyaluronidase 
through the body can reach the 
sensitized zone (nose, bronchi, 
etc.); and 
also applicable to cancer, that 
selectivity takes place at a dis-
tance, also as in this case pro-
ducing a form of immulogical 
paralysis. 
What is more, there also actually 
exists an association between cancer-cells 
and hyaluronidase; it is known that cancer 
cells tend to lose their attachment and 
stick to foreign substances (Abercrombie 
et al., 1963). Also extracts of malignant 
tumours show the presence of hyaluroni-
dase (Waiter and Israel, 1965f). Could this 
possibly mean that an attempt is being 
made by the tumour itself towards natu-
ral treatment on the very same lines here 
suggested as artificial therapy? With re-
gard to the use of hyaluronidase a sober-
ing thought is that in bladder cancer from 
certain aromatics hyaluronidase can ac-
tually be an adjuvant towards tumour for-
mation (Waiter and Israel, 1965f). 
Should the carcinogen-hyaluronidase 
combination show any therapeutical pro-
mise, there seems to be no reason why it 
should not be used together with more 
orthodox methods. Should the working 
theory of carcinogenesis and subsequent 
cancer treatment here presented warrant 
the time and expenditure, it is open to 
testing by animal experimentation. It 
should not take long to accept or dis-
credit it. 
Postscript 
The conclusion arrived at from pure 
reasoning, that an attempt should be made 
to cure cancer by carcinogen administered 
systemically with hyaluronidase, is 
strongly supported by the work of Stari-
kova and Vasiliev. Popper's experiments 
with hyaluronidase in allergy are equally 
encouraging. As both these articles came 
to the author's attention when this paper 
was already drafted they give even strong-
er support to what might otherwise have 
appeared to be mere fantasy. 
Summary 
It is suggested that cancer might be 
the body's immune response to particulate 
noxious substances (hence "carcinogen") 
which the ordinary defensive systems are 
unable to deal with. The response would 
consist in the survival and proliferation 
of mutated local tissue cells (cancer cells); 
on the principle of Darwinian evolution, 
which become actual or potential immu-
nocytes against the carcinogen. Owing to 
a physical barrier, carcinogen can never 
effectually come in contact with these new 
cells, which therefore proliferate indefi-
nitely as a parasitic colony of unicellular 
organisms. 
Should it be considered that there are 
sufficient grounds for accepting cancer as 
an immune response, it is suggested that 
treatment might take the form of immuno-
suppression. Large doses of carcinogen 
administered systemically might be able 
to produce immunological paralysis with 
disappearance of cancer cells. In the hope 
of liquefying the tumour's intercellular 
spaces to facilitate spread of carcinogens, 
it is suggested that the latter be adminis-
tered together with hyalurodinase. 
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